Chapter 6.6 Microdialysis for characterization of PK/PD relationships

Handbook of Behavioral Neuroscience

Volumn 16, Issue , 2006, Pages 589-600

  Hammarlund Udenaes, Margareta ^a  

^a Faculty of Pharmacy   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649684016     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-7339(06)16031-2     Document Type: Review

References (79)

1. Alves O.L., Doyle A.J., Clausen T., Gilman C., and Bullock R. Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis. Ann. N.Y. Acad. Sci. 993 (2003) 25-34 discussion 48-53
2. Anand B.S., Atluri H., and Mitra A.K. Validation of an ocular microdialysis technique in rabbits with permanently implanted vitreous probes: systemic and intravitreal pharmacokinetics of fluorescein. Int. J. Pharm. 281 (2004) 79-88
3. Ao X., Rotundo R.F., Loegering D.J., and Stenken J.A. In vivo microdialysis sampling of cytokines produced in mice given bacterial lipopolysaccharide. J. Microbiol. Methods 62 (2005) 327-336
4. Aoyama T., Kotaki H., Sawada Y., and Iga T. Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats. Psychopharmacology (Berl.) 127 (1996) 117-122
5. Benturquia N., Parrot S., Sauvinet V., Renaud B., and Denoroy L. Simultaneous determination of vigabatrin and amino acid neurotransmitters in brain microdialysates by capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 806 (2004) 237-244
6. Bouw M.R., Gårdmark M., and Hammarlund-Udenaes M. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats - a microdialysis study. Pharm. Res. 17 (2000) 1220-1227
7. Bouw M.R., Xie R., Tunblad K., and Hammarlund-Udenaes M. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats - pharmacokinetic/pharmacodynamic modelling. Br. J. Pharmacol. 134 (2001) 1796-1804
8. Brunner M., Derendorf H., and Muller M. Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs. Curr. Opin. Pharmacol. 5 (2005) 495-499
9. Brunner M., Hollenstein U., Delacher S., Jager D., Schmid R., Lackner E., Georgopoulos A., Eichler H.G., and Muller M. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob. Agents Chemother. 43 (1999) 1307-1309
10. Brunner M., Pernerstorfer T., Mayer B.X., Eichler H.G., and Muller M. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit. Care Med. 28 (2000) 1754-1759
11. Brunner M., Stabeta H., Moller J.G., Schrolnberger C., Erovic B., Hollenstein U., Zeitlinger M., Eichler H.G., and Muller M. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob. Agents Chemother. 46 (2002) 3724-3730
12. Chenel M., Marchand S., Dupuis A., Lamarche I., Paquereau J., Pariat C., and Couet W. Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats. Br. J. Pharmacol. 142 (2004) 323-330
13. Clinckers R., Smolders I., Meurs A., Ebinger G., and Michotte Y. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci. Lett. 390 (2005) 48-53
14. Clough G.F. Microdialysis of large molecules. AAPS J. 7 (2005) E686-E692
15. Cosford R.J., Parsons L.H., and Justice Jr. J.B. Effect of tetrodotoxin and potassium infusion on microdialysis extraction fraction and extracellular dopamine in the nucleus accumbens. Neurosci. Lett. 178 (1994) 175-178
16. Cosford R.J., Vinson A.P., Kukoyi S., and Justice Jr. J.B. Quantitative microdialysis of serotonin and norepinephrine: pharmacological influences on in vivo extraction fraction. J. Neurosci. Methods 68 (1996) 39-47
17. Dabrosin C. Microdialysis - an in vivo technique for studies of growth factors in breast cancer. Front. Biosci. 10 (2005) 1329-1335
18. Dai H., Chen Y., Elmquist W.F., Yang H., Wang Q., and Elmquist W.F. Distribution of the novel antifolate pemetrexed to the brain. J. Pharmacol. Exp. Ther. 315 (2005) 222-229
19. de Lange E.C., de Bock G., Schinkel A.H., de Boer A.G., and Breimer D.D. BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. Pharm. Res. 15 (1998) 1657-1665
20. de Lange E.C., Marchand S., van den Berg D., van der Sandt I.C., de Boer A.G., Delon A., Bouquet S., and Couet W. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur. J. Pharm. Sci. 12 (2000) 85-93
21. de Lange E.C., Ravenstijn P.G., Groenendaal D., and van Steeg T.J. Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling. AAPS J. 7 (2005) E532-E543
22. Delacher S., Derendorf H., Hollenstein U., Brunner M., Joukhadar C., Hofmann S., Georgopoulos A., Eichler H.G., and Muller M. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J. Antimicrob. Chemother. 46 (2000) 733-739
23. Dohmen C., Bosche B., Graf R., Staub F., Kracht L., Sobesky J., Neveling M., Brinker G., and Heiss W.D. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 34 (2003) 2152-2158
24. Dubey R.K., McAllister C.B., Inoue M., and Wilkinson G.R. Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation. J. Clin. Invest. 84 (1989) 1155-1159
25. Duvvuri S., Rittenhouse K.D., and Mitra A.K. Microdialysis assessment of drug delivery systems for vitreoretinal targets. Adv. Drug. Deliv. Rev. 57 (2005) 2080-2091
26. Ederoth P., Tunblad K., Bouw R., Lundberg C.J., Ungerstedt U., Nordstrom C.H., and Hammarlund-Udenaes M. Blood-brain barrier transport of morphine in patients with severe brain trauma. Br. J. Clin. Pharmacol. 57 (2004) 427-435
27. Graumlich J.F., McLaughlin R.G., Birkhahn D., Shah N., Burk A., Jobe P.C., and Dailey J.W. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur. J. Pharmacol. 369 (1999) 305-311
28. Gupta A., Chatelain P., Massingham R., Jonsson E.N., and Hammarlund-Udenaes M. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu). Drug. Metab. Dispos. 34 (2006) 318-323
29. Hammarlund-Udenaes M. The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv. Drug Deliv. Rev. 45 (2000) 283-294
30. Hammarlund-Udenaes M., Paalzow L.K., and de Lange E.C. Drug equilibration across the blood-brain barrier - pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14 (1997) 128-134
31. Heinzen E.L., and Pollack G.M. Pharmacokinetics and pharmacodynamics of l-arginine in rats: a model of stimulated neuronal nitric oxide synthesis. Brain Res. 989 (2003) 67-75
32. Hillman J., Aneman O., Anderson C., Sjogren F., Saberg C., and Mellergard P. A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery 56 (2005) 1264-1268 discussion 1268-1270
33. Hocht C., DiVerniero C., Opezzo J.A., Taira C.A., Hocht C., Opezzo J.A., and Taira C.A. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers. J. Pharmacol. Toxicol. Methods 52 (2005) 244-250
34. Hocht C., Opezzo J.A., and Taira C.A. Hypothalamic antihypertensive effect of metoprolol in chronic aortic coarctated rats. Clin. Exp. Pharmacol. Physiol. 32 (2005) 681-686
35. Huang Y., Ji P., Inano A., Yang Z., Giebink G.S., and Sawchuk R.J. Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla. J. Pharm. Sci. 90 (2001) 2088-2098
36. Hutchinson P.J., O'Connell M.T., Nortje J., Smith P., Al-Rawi P.G., Gupta A.K., Menon D.K., and Pickard J.D. Cerebral microdialysis methodology - evaluation of 20 kDa and 100 kDa catheters. Physiol. Meas. 26 (2005) 423-428
37. Islinger F., Bouw R., Stahl M., Lackner E., Zeleny P., Brunner M., Muller M., Eichler H.G., and Joukhadar C. Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob. Agents Chemother. 48 (2004) 4246-4249
38. Johansen M.J., Newman R.A., and Madden T. The use of microdialysis in pharmacokinetics and pharmacodynamics. Pharmacotherapy 17 (1997) 464-481
39. Joukhadar C., Frossard M., Mayer B.X., Brunner M., Klein N., Siostrzonek P., Eichler H.G., and Muller M. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit. Care Med. 29 (2001) 385-391
40. Joukhadar C., Klein N., Dittrich P., Zeitlinger M., Geppert A., Skhirtladze K., Frossard M., Heinz G., and Muller M. Target site penetration of fosfomycin in critically ill patients. J. Antimicrob. Chemother. 51 (2003) 1247-1252
41. Joukhadar C., Klein N., Mayer B.X., Kreischitz N., Delle-Karth G., Palkovits P., Heinz G., and Muller M. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit. Care Med. 30 (2002) 1478-1482
42. Justice Jr. J.B. Quantitative microdialysis of neurotransmitters. J. Neurosci. Methods 48 (1993) 263-276
43. Karjagin J., Pahkla R., Karki T., and Starkopf J. Distribution of metronidazole in muscle tissue of patients with septic shock and its efficacy against Bacteroides fragilis in vitro. J. Antimicrob. Chemother. 55 (2005) 341-346
44. Kopacz D.J., Bernards C.M., Allen H.W., Landau C., Nandy P., Wu D., and Lacouture P.G. A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules. Anesth. Analg. 97 (2003) 124-131
45. Kreilgaard M., Kemme M.J., Burggraaf J., Schoemaker R.C., and Cohen A.F. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm. Res. 18 (2001) 593-599
46. Langer O., Karch R., Muller U., Dobrozemsky G., Abrahim A., Zeitlinger M., Lackner E., Joukhadar C., Dudczak R., Kletter K., Muller M., and Brunner M. Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J. Nucl. Med. 46 (2005) 1835-1841
47. Letrent S.P., Pollack G.M., Brouwer K.R., and Brouwer K.L. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab. Dispos. 27 (1999) 827-834
48. Lotsch J., Schmidt R., Vetter G., Schmidt H., Niederberger E., Geisslinger G., and Tegeder I. Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein. J. Neurochem. 83 (2002) 241-248
49. Marchand S., Dahyot C., Lamarche I., Mimoz O., and Couet W. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob. Agents Chemother. 49 (2005) 2356-2361
50. Marchand S., Chenel M., Lamarche I., and Couet W. Pharmacokinetic modeling of free amoxicillin concentrations in rat muscle extracellular fluids determined by microdialysis. Antimicrob. Agents Chemother. 49 (2005) 3702-3706
51. Muller M., Stass H., Brunner M., Moller J.G., Lackner E., and Eichler H.G. Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob. Agents Chemother. 43 (1999) 2345-2349
52. Muller M., Brunner M., Hollenstein U., Joukhadar C., Schmid R., Minar E., Ehringer H., and Eichler H.G. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob. Agents Chemother. 43 (1999) 2056-2058
53. Olson R., and Justice J. Quantitative microdialysis under transient conditions. Anal. Chem. 65 (1993) 1017-1022
54. Pan W.J., and Hedaya M.A. An animal model for simultaneous pharmacokinetic/pharmacodynamic investigations: application to cocaine. J. Pharmacol. Toxicol. Methods 39 (1998) 1-8
55. Parsons L.H., and Justice Jr. J.B. Quantitative approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 8 (1994) 189-220
56. Raje S., Cornish J., Newman A.H., Cao J., Katz J.L., and Eddington N.D. Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharm. Res. 22 (2005) 603-612
57. Rittenhouse K.D., and Pollack G.M. Microdialysis and drug delivery to the eye. Adv. Drug Deliv. Rev. 45 (2000) 229-241
58. Sauermann R., Delle-Karth G., Marsik C., Steiner I., Zeitlinger M., Mayer-Helm B.X., Georgopoulos A., Muller M., and Joukhadar C. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob. Agents Chemother. 49 (2005) 650-655
59. Sauermann R., Zeitlinger M., Erovic B.M., Marsik C., Georgopoulos A., Muller M., Brunner M., and Joukhadar C. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int. J. Antimicrob. Agents 22 (2003) 574-578
60. Smith A.D., and Justice J.B. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods 54 (1994) 75-82
61. Stahle L., Segersvard S., and Ungerstedt U. Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissues in rats. Life Sci. 49 (1991) 1843-1852
62. Stain-Texier F., Boschi G., Sandouk P., and Scherrmann J.M. Elevated concentrations of morphine 6-beta-d-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability. Br. J. Pharmacol. 128 (1999) 917-924
63. Sun H., Bungay P.M., and Elmquist W.F. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. J. Pharmacol. Exp. Ther. 297 (2001) 991-1000
64. Sun H., Dai H., Shaik N., Elmquist W.F., and Bungay P.M. Drug efflux transporters in the CNS. Adv. Drug Deliv. Rev. 55 (2003) 83-105
65. Syvänen S., Xie R., Sahin S., and Hammarlund-Udenaes M. Pharmacokinetic consequences of active drug efflux at the blood-brain barrier. Pharm. Res 23 (2006) 705-717
66. Thompson A.C., Justice Jr. J.B., and McDonald J.K. Quantitative microdialysis of neuropeptide Y. J. Neurosci. Methods 60 (1995) 189-198
67. Tunblad K., Ederoth P., Gardenfors A., Hammarlund-Udenaes M., and Nordstrom C.H. Altered brain exposure of morphine in experimental meningitis studied with microdialysis. Acta Anaesthesiol. Scand. 48 (2004) 294-301
68. Tunblad K., Hammarlund-Udenaes M., and Jonsson E.N. Influence of probenecid on the delivery of morphine-6-glucuronide to the brain. Eur. J. Pharm. Sci. 24 (2005) 49-57
69. Tunblad K., Jonsson E.N., and Hammarlund-Udenaes M. Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm. Res. 20 (2003) 618-623
70. Wang Q., Yang H., Miller D.W., and Elmquist W.F. Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem. Biophys. Res. Commun. 211 (1995) 719-726
71. Wang X., Ratnaraj N., and Patsalos P.N. The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus). Seizure 13 (2004) 574-581
72. Weikop P., Egestad B., and Kehr J. Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain. J. Neurosci. Methods 140 (2004) 59-65
73. Welty D.F., Schielke G.P., Vartanian M.G., and Taylor C.P. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res. 16 (1993) 175-181
74. Wong S.L., Wang Y., and Sawchuk R.J. Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis. Pharm. Res. 9 (1992) 332-338
75. Xie R., Bouw M.R., and Hammarlund-Udenaes M. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport. Br. J. Pharmacol. 131 (2000) 1784-1792
76. Xie R., and Hammarlund-Udenaes M. Blood-brain barrier equilibration of codeine in rats studied with microdialysis. Pharm. Res. 15 (1998) 570-575
77. Xie R., Hammarlund-Udenaes M., de Boer A.G., and de Lange E.C. The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice. Br. J. Pharmacol. 128 (1999) 563-568
78. Yang H., Wang Q., and Elmquist W.F. Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. Pharm. Res. 13 (1996) 1570-1575
79. Zeitlinger M.A., Dehghanyar P., Mayer B.X., Schenk B.S., Neckel U., Heinz G., Georgopoulos A., Muller M., and Joukhadar C. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob. Agents Chemother. 47 (2003) 3548-3553